Navigation Links
Bacterial protein 'mops up' viruses found in contaminated water supplies
Date:12/17/2011

Access to clean water is a necessity often taken for granted. However UNICEF estimates that 900 million people across the world do not have access to safe drinking water. New research published in BioMed Central's open access journal BMC Biotechnology shows that an enteric virus-binding protein (EVBP), isolated from bacteria found in activated sludge, is able to capture viruses often present in contaminated water.

One of the difficulties in measuring viral contamination in water is that viruses may be present at a very low concentration yet still make people ill. Even a single enteric virus can infect a human and cause gastroenteritis, and these viruses can survive for a long time in water.

Researchers from Tohoku University and Hokkaido University used activated sludge, produced during sewage treatment by aerating the sewage and allowing bacteria to breakdown organic material, as starting material in their search for a protein able to bind to enteric viruses. Using PCR the researchers isolated the gene coding for one of the subunits of GroEL from sludge DNA. GroEL is a 14 subunit 'chaperone' protein which ensures that proteins are folded correctly during their manufacture.

Using biochemical and enzymatic assays the subunit was found to be able to capture enteric viruses. GroEL is able to bind to hydrophobic amino acids on the surface of proteins and it is thought that the newly isolated EVBP similarly binds to hydrophobic areas on the surfaces of viruses and viral fragments.

Dr Daisuke Sano from Hokkaido University explained, "Unlike virus-specific and expensive antibodies, EVBP bound all the enteric viruses we tested (norovirus, rotavirus and poliovirus). Once developed this easy-to-use method could be used to detect low concentrations of viruses in the clinic or environment."


'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central
Source:Eurekalert

Page: 1

Related biology technology :

1. Gene against bacterial attack unravelled
2. Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
3. DNA2.0 Introduces Freedom of Expression With a New Family of Bacterial Expression Vect:ors
4. Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe
5. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
6. Biologists discover an extra layer of protection for bacterial spores
7. Scientists ID bacterial genes that improve plant growth
8. First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers
9. Synthetic Genomics Inc. Applauds the Venter Institutes Work in Creating the First Synthetic Bacterial Cell
10. Scientists boot up a bacterial cell with a synthetic genome
11. Biologists discover an extra layer of protection for bacterial spores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):